CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (3) , 460-468
- https://doi.org/10.1067/mai.2002.127512
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (Tgf)-β1 PlasmidThe Journal of Experimental Medicine, 2000
- Endogenous interleukin‐10 suppresses allergen‐induced airway inflammation and nonspecific airway responsivenessClinical and Experimental Allergy, 2000
- IL-10: Evolving conceptsJournal of Allergy and Clinical Immunology, 1998
- T1 and T2 CD4+ cells in human allergic diseasesJournal of Allergy and Clinical Immunology, 1997
- Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary AspergillosisThe Journal of Experimental Medicine, 1997
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.The Journal of Experimental Medicine, 1995
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Lymphokine Production by Human T Cells in Disease StatesAnnual Review of Immunology, 1994
- Role of Cytokines in the Differentiation of CD4+ T‐Cell Subsets in vivoImmunological Reviews, 1991
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989